These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 8795640)

  • 1. Neuropeptide Y-mediated long-term depression of excitatory activity in suprachiasmatic nucleus neurons.
    van den Pol AN; Obrietan K; Chen G; Belousov AB
    J Neurosci; 1996 Sep; 16(18):5883-95. PubMed ID: 8795640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropeptide Y depresses GABA-mediated calcium transients in developing suprachiasmatic nucleus neurons: a novel form of calcium long-term depression.
    Obrietan K; van den Pol AN
    J Neurosci; 1996 May; 16(10):3521-33. PubMed ID: 8627385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropeptide Y inhibits hypocretin/orexin neurons by multiple presynaptic and postsynaptic mechanisms: tonic depression of the hypothalamic arousal system.
    Fu LY; Acuna-Goycolea C; van den Pol AN
    J Neurosci; 2004 Oct; 24(40):8741-51. PubMed ID: 15470140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple NPY receptors coexist in pre- and postsynaptic sites: inhibition of GABA release in isolated self-innervating SCN neurons.
    Chen G; van den Pol AN
    J Neurosci; 1996 Dec; 16(23):7711-24. PubMed ID: 8922427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase shifting of circadian rhythms and depression of neuronal activity in the rat suprachiasmatic nucleus by neuropeptide Y: mediation by different receptor subtypes.
    Gribkoff VK; Pieschl RL; Wisialowski TA; van den Pol AN; Yocca FD
    J Neurosci; 1998 Apr; 18(8):3014-22. PubMed ID: 9526018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The neuropeptide Y Y5 receptor mediates the blockade of "photic-like" NMDA-induced phase shifts in the golden hamster.
    Yannielli PC; Harrington ME
    J Neurosci; 2001 Jul; 21(14):5367-73. PubMed ID: 11438613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circadian phase shifts to neuropeptide Y In vitro: cellular communication and signal transduction.
    Biello SM; Golombek DA; Schak KM; Harrington ME
    J Neurosci; 1997 Nov; 17(21):8468-75. PubMed ID: 9334419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attenuation of circadian light induced phase advances and delays by neuropeptide Y and a neuropeptide Y Y1/Y5 receptor agonist.
    Lall GS; Biello SM
    Neuroscience; 2003; 119(2):611-8. PubMed ID: 12770573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of excitatory amino acids and neuropeptide Y on the discharge activity of suprachiasmatic neurons in rat brain slices.
    Schmahl C; Böhmer G
    Brain Res; 1997 Jan; 746(1-2):151-63. PubMed ID: 9037494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of neuropeptide Y, peptide YY, and pancreatic polypeptide inhibition of identified green fluorescent protein-expressing GABA neurons in the hypothalamic neuroendocrine arcuate nucleus.
    Acuna-Goycolea C; Tamamaki N; Yanagawa Y; Obata K; van den Pol AN
    J Neurosci; 2005 Aug; 25(32):7406-19. PubMed ID: 16093392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropeptide Y-induced phase shifts of PER2::LUC rhythms are mediated by long-term suppression of neuronal excitability in a phase-specific manner.
    Besing RC; Hablitz LM; Paul JR; Johnson RL; Prosser RA; Gamble KL
    Chronobiol Int; 2012 Mar; 29(2):91-102. PubMed ID: 22324550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigations into neuropeptide Y-mediated presynaptic inhibition in cultured hippocampal neurones of the rat.
    Bleakman D; Harrison NL; Colmers WF; Miller RJ
    Br J Pharmacol; 1992 Oct; 107(2):334-40. PubMed ID: 1358389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenosine pre- and postsynaptic modulation of glutamate-dependent calcium activity in hypothalamic neurons.
    Obrietan K; Belousov AB; Heller HC; van den Pol AN
    J Neurophysiol; 1995 Nov; 74(5):2150-62. PubMed ID: 8592203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional interaction between neuropeptide Y receptors and modulation of calcium channels in the rat hippocampus.
    Silva AP; Carvalho AP; Carvalho CM; Malva JO
    Neuropharmacology; 2003 Feb; 44(2):282-92. PubMed ID: 12623227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropeptide Y attenuates NMDA-induced phase shifts in the SCN of NPY Y1 receptor knockout mice in vitro.
    Soscia SJ; Harrington ME
    Brain Res; 2004 Oct; 1023(1):148-53. PubMed ID: 15364030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropeptide Y phase shifts circadian rhythms in vivo via a Y2 receptor.
    Huhman KL; Gillespie CF; Marvel CL; Albers HE
    Neuroreport; 1996 May; 7(7):1249-52. PubMed ID: 8817542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropeptide Y blocks serotonergic phase shifts of the suprachiasmatic circadian clock in vitro.
    Prosser RA
    Brain Res; 1998 Oct; 808(1):31-41. PubMed ID: 9795117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presynaptic GABAB autoreceptor modulation of P/Q-type calcium channels and GABA release in rat suprachiasmatic nucleus neurons.
    Chen G; van den Pol AN
    J Neurosci; 1998 Mar; 18(5):1913-22. PubMed ID: 9465016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropeptide Y and glutamate block each other's phase shifts in the suprachiasmatic nucleus in vitro.
    Biello SM; Golombek DA; Harrington ME
    Neuroscience; 1997 Apr; 77(4):1049-57. PubMed ID: 9130786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropeptide Y rapidly reduces Period 1 and Period 2 mRNA levels in the hamster suprachiasmatic nucleus.
    Fukuhara C; Brewer JM; Dirden JC; Bittman EL; Tosini G; Harrington ME
    Neurosci Lett; 2001 Nov; 314(3):119-22. PubMed ID: 11704298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.